Compliance Rate

Compliance Rate 100.0%
Compliant submissions 1
Incompliant submissions 0
Total trials 1

My Organizations' Clinical Trials

Showing 125 of 3173 entries
View as:

A Study Of Different Doses Of TBC3711 In Patients With Uncontrolled High Blood Pressure Already Taking Medications For High Blood Pressure.

Phase: N/A Priority: Normal
NCT ID: NCT00272961 Org: User:
Start: 01/31/06 End: 08/31/08 Due: 08/31/09

Concomitant Administration of 13-valent Pneumococcal Conjugate Vaccine (13vPnC) With Influenza Vaccine in 23-valent Pneumococcal Polysaccharide (23vPS) Pre-vaccinated Adults.

Phase: N/A Priority: Normal
NCT ID: NCT02124161 Org: User:
Start: 09/30/14 End: 05/31/15 Due: 05/31/16

Clinical Study With Axitinib In Advanced Kidney Cancer, Who Have Failed First Line Treatment

Phase: N/A Priority: Normal
NCT ID: NCT01473043 Org: User:
Start: 03/31/12 End: 03/31/14 Due: 03/31/15

Radiolabel ADME (Absorption, Distribution, Metabolism, and Excretion) Study Of [14C] PF-00868554 In Healthy Adult Male Subjects

Phase: N/A Priority: Normal
NCT ID: NCT00823745 Org: User:
Start: 01/31/09 End: 02/28/09 Due: 02/28/10

Study Evaluating the Safety and Efficacy of Etanercept in Patients With Psoriatic Arthritis Treated by Dermatologists

Phase: N/A Priority: Normal
NCT ID: NCT00293709 Org: User:
Start: 01/31/06 End: 02/28/13 Due: 02/28/14

Study of Talazoparib, a PARP Inhibitor, in Patients With Advanced or Recurrent Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT01286987 Org: User:
Start: 01/03/11 End: 01/30/17 Due: 01/30/18

A Study Comparing PF-05089771 TS Capsule To PF-05089771 TS Oral Dispersion In The Fasted State

Phase: N/A Priority: Normal
NCT ID: NCT01690351 Org: User:
Start: 09/30/12 End: 09/30/12 Due: 09/30/13

A Study to Understand the Use of Palbociclib in Canadian Patients With Breast Cancer That Has Spread to Other Organs

Phase: N/A Priority: Normal
NCT ID: NCT06003114 Org: User:
Start: 10/06/23 End: 02/22/24 Due: 02/22/25

Comparing Irinotecan and 5 FU/FA To 5-FU/FA After Resection Of Liver Metastases For Colorectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00143403 Org: User:
Start: 12/31/01 End: 09/30/09 Due: 09/30/10

Study Of SU011248 (Sunitinib) Given In A Continuous Daily Regimen In Patients With Advanced Renal Cell Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00137423 Org: User:
Start: 05/31/05 End: 05/31/08 Due: 05/31/09

Study On Utilization Of Cabergoline For Compliance With Risk Minimization Activities (SUCRE)

Phase: N/A Priority: Normal
NCT ID: NCT01270711 Org: User:
Start: 11/30/10 End: 02/28/13 Due: 02/28/14

Treatment Patterns & Clinical Outcomes of Palbociclib Combinations in HR+HER2-MBC

Phase: N/A Priority: Normal
NCT ID: NCT04937660 Org: User:
Start: 07/15/21 End: 04/30/25 Due: 04/30/26

Study In Healthy Subjects To Evaluate The Changes In The Protein sAPP-Alpha In Cerebrospinal Fluid Following A Single Oral Dose Of PF-04995274

Phase: N/A Priority: Normal
NCT ID: NCT01193062 Org: User:
Start: 09/30/10 End: 01/31/11 Due: 01/31/12

Study Comparing Bevacizumab + Temsirolimus vs. Bevacizumab + Interferon-Alfa In Advanced Renal Cell Carcinoma Subjects

Phase: N/A Priority: Normal
NCT ID: NCT00631371 Org: User:
Start: 04/30/08 End: 04/30/15 Due: 04/30/16

To Evaluate The Relationship Between Plasma Drug Levels And Receptor Binding In Brain Using PET (Positron Emission Tomography) In Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01253655 Org: User:
Start: 11/30/10 End: 03/31/11 Due: 03/31/12

A Bioequivalence Study Comparing A Fixed Dose Combination Formulation Of Myrin P Forte That Contains Rifampicin, Isoniazid, Ethambutol And Pyrazinamide Per Tablet To An Equivalent Dose Of Single Drug Reference Preparations Of Similar Combination Following Oral Administration In Healthy Adults

Phase: N/A Priority: Normal
NCT ID: NCT01399788 Org: User:
Start: 07/31/11 End: 08/31/11 Due: 08/31/12

A Study Of CP-690,550 In Stable Kidney Transplant Patients

Phase: N/A Priority: Normal
NCT ID: NCT01710033 Org: User:
Start: 09/30/03 End: 04/30/05 Due: 04/30/06

A Study to Describe the Breast Cancer Patient Population, Treatment, and Results in Indian Patients Receiving Combinations of the Medicines Called Palbociclib for Advanced Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT05584644 Org: User:
Start: 05/24/21 End: 02/22/22 Due: 02/22/23

Study to Estimate the Relative Bioavailability Compared to Commercial Extended-release Tablet Formulation and the Effects of Food Or Sprinkling on Applesauce for Fesoterodine Sustained-release Beads-in-capsule Formulations in Healthy Adult Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02160158 Org: User:
Start: 07/31/14 End: 12/31/14 Due: 12/31/15

A Study To Investigate The Safety And Efficacy Properties Of PF-00547659 In Patients With Active Ulcerative Colitis

Phase: N/A Priority: Normal
NCT ID: NCT00928681 Org: User:
Start: 09/30/05 End: 10/31/08 Due: 10/31/09

Study Evaluating Efficacy and Safety of PF-04965842 and Dupilumab in Adult Subjects With Moderate to Severe Atopic Dermatitis on Background Topical Therapy

Phase: N/A Priority: Normal
NCT ID: NCT03720470 Org: User:
Start: 10/29/18 End: 03/06/20 Due: 03/06/21

Bioavailability and Food Effect Study of Two Formulations of PF-06650833

Phase: N/A Priority: Normal
NCT ID: NCT03308110 Org: User:
Start: 09/08/17 End: 01/11/18 Due: 01/11/19

Study to Investigate the Safety, Tolerability, Pharmacokinetics of PF-06305591 in Healthy Male and Female Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01747941 Org: User:
Start: 11/30/12 End: 05/31/13 Due: 05/31/14

A Three Day Trial of Azithromycin Plus Chloroquine for the Treatment of Uncomplicated Plasmodium Falciparum Malaria

Phase: N/A Priority: Normal
NCT ID: NCT00282919 Org: User:
Start: 03/31/06 End: 02/29/08 Due: 02/28/09

A Study of Duloxetine Hydrochloride Hard Gelatinous Capsule Compared To Cymbalta

Phase: N/A Priority: Normal
NCT ID: NCT03729284 Org: User:
Start: 03/30/20 End: 06/07/20 Due: 06/07/21